logo
Share SHARE
FONT-SIZE Plus   Neg

Moser Baer Launches Biometric Pen Drives To Strengthen Data Security

Moser Baer India Ltd. announced the launching of a unique biometric pen drive, aimed towards maintaining data confidentiality, protection from data theft and sensitive data leaks.

Easily installable, the biometric pen drive will provide stronger data security, password protection, strong user authentication, file encryption and carries separate public and private space on the disk.

Color coded white, these drives have the capacity of 16GB and is compatible with Windows ME/2000/XP/Vista/MAC OS 9.0 or Linux Kernal 2.4.2. The pen drive has a warranty of two years.

Senior Vice President-Domestic Sales and Marketing Deepak Shetty said, "This is one of our latest offering to our customers to further strengthen the security of the pen drives. The newly launched pen drives have an easy four step installation. The product will help fulfill a major need of the hour in the face of data theft and help fight cyber threats while securing data through its public and private space on the disk."

At the BSE, Moser Baer India closed Friday's trading at Rs.2.91, down 4.90 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

0 Articles
Editors Pick
Chipotle Mexican Grill Inc. (CMG) on Monday reported a surge in profit for the first quarter, as revenues climbed 20 percent on new restaurant openings and strong same-restaurant sales. Earnings for the quarter trounced Wall Street expectations, but revenues fell short of estimates, hurt largely... Yahoo reported a plunge in profit, hurt by lower prices for display ads as well as one-time charges. Its results fell short of Street estimates, denoting the challenges CEO Marissa Mayer faces in implementing her turnaround plans at the Internet company. Amgen Inc. (AMGN) on Tuesday reported a surge in profit for the first quarter, as revenues grew 11 percent on better pricing and strong demand with research costs falling. Both earnings and revenues for the quarter trumped analysts' estimates. Moving ahead, the drug maker raised its outlook for the full...
comments powered by Disqus
Follow RTT